Problem statement: Answer the multiple-choice question.
Query: Which drug has a 3.211% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a: COCc1cc(OC)nc(-c2csc(C)n2)n1
b: CC1(c2ccccc2)NC(=O)N(CC(=O)Nc2cc(Cl)ccc2N2CCOCC2)C1=O
c: CCc1cc(=O)oc2c(C)c(OC(C)C(=O)NCCCN3CCOCC3)ccc12
d: Cc1csc(Nc2ccccc2)n1
Answer: c. CCc1cc(=O)oc2c(C)c(OC(C)C(=O)NCCCN3CCOCC3)ccc12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCc1cc(=O)oc2c(C)c(OC(C)C(=O)NCCCN3CCOCC3)ccc12
CCc1cc(=O)oc2c(C)c(OC(C)C(=O)NCCCN3CCOCC3)ccc12
2-(4-ethyl-8-methyl-2-oxochromen-7-yl)oxy-N-(3-morpholin-4-ylpropyl)propanamide